According to Meridian Bioscience's latest financial reports the company's total debt is โน2.65 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-09-30 | โน2.51 B | -48.52% |
2021-09-30 | โน4.89 B | -11.79% |
2020-09-30 | โน5.54 B | 3.19% |
2019-09-30 | โน5.37 B | 47.81% |
2018-09-30 | โน3.63 B | 1.94% |
2017-09-30 | โน3.56 B | -8.51% |
2016-09-30 | โน3.90 B | |
2006-09-30 | โน82.55 M | -42.04% |
2005-09-30 | โน0.14 B | -82.58% |
2004-09-30 | โน0.81 B | -21.87% |
2003-09-30 | โน1.04 B | -21.41% |
2002-09-30 | โน1.33 B | -14.06% |
2001-09-30 | โน1.54 B | -3.79% |
2000-09-30 | โน1.61 B | 39.04% |
1999-09-30 | โน1.15 B | 31.07% |
1998-09-30 | โน0.88 B | 17.38% |
1997-09-30 | โน0.75 B | -9.49% |
1996-09-30 | โน0.83 B |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() QuidelOrtho QDEL | โน230.93 B | 8,603.04% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | โน2.930 T | 110,340.29% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | โน1.651 T | 62,147.63% | ๐บ๐ธ USA |
![]() Hologic HOLX | โน216.94 B | 8,075.86% | ๐บ๐ธ USA |